<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>47</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Paizis, I</style></author><author><style face="normal" font="default" size="100%">Pantos, C.</style></author><author><style face="normal" font="default" size="100%">Malliopoulou, V</style></author><author><style face="normal" font="default" size="100%">Karamanoli, E</style></author><author><style face="normal" font="default" size="100%">Moraitis, P</style></author><author><style face="normal" font="default" size="100%">Varonos, D</style></author><author><style face="normal" font="default" size="100%">Cokkinos, D.V.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">T4 pretreatment and ischaemic preconditioning have additive cardioprotective effect possibly mediated by p38 MAPK attenuation during ischaemia</style></title><secondary-title><style face="normal" font="default" size="100%">EUROPEAN HEART JOURNAL</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2002</style></year></dates><publisher><style face="normal" font="default" size="100%">WB SAUNDERS CO LTD 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND</style></publisher><volume><style face="normal" font="default" size="100%">23</style></volume><pages><style face="normal" font="default" size="100%">219–219</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>